Literature DB >> 30900247

Objectively measuring social attention of thyroid neck scars and transoral surgery using eye tracking.

Michelle C Juarez1, Lisa Ishii2,3, Jason C Nellis3, Kristin Bater1, Pauline P Huynh1, Nicholas Fung1, Halley Darrach1, Jonathon O Russell3,4, Masaru Ishii3,5.   

Abstract

OBJECTIVE: Measure the social attention of thyroid neck scars and transoral surgery using eye tracking.
METHODS: Observers viewed images of patients with thyroid neck scars, control patients with no scars, and patients who underwent transoral thyroidectomy as an eye-tracking monitor recorded their eye movements. Hotelling's multivariate analysis, followed by planned posthypothesis testing, were used to compare fixation times for the central triangle (CT), peripheral face, and neck between the three groups. To assess if these gaze patterns would normalize with transoral surgery, a two-sample t test was done to assess for differences in neck fixations between control and transoral patients and between transoral and traditional thyroidectomy.
RESULTS: One hundred and thirty participants completed the eye-tracking experiment (mean age 24.3 years, 65 females). Observers directed the majority of their attention to the CT in both control and scar patients. Observers paid more attention to the neck (103.72 ms, P < .0001, 95% confidence interval [CI] [55, 152] ms) and less to the peripheral face (115.50 ms, P = .01, 95% CI [19, 211] ms) in patients with neck scars than in control patients. Furthermore, transoral surgery eliminated this attentional distraction wherein there was no difference in the fixation time to the neck (-39.198 ms P = .16, 95% CI [-93.978, 15.5816] ms) between controls and those who underwent transoral surgery.
CONCLUSION: Observers directed their gaze away from the face and toward the neck in patients with thyroid neck scars. Furthermore, this distraction was eliminated with tranoral surgery. These findings shed light onto the altered observer perceptions of patients with thyroid neck scars. LEVEL OF EVIDENCE: NA Laryngoscope, 129:2789-2794, 2019.
© 2019 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Thyroid neck scar; eye tracking; thyroid surgery; transoral thyroidectomy

Year:  2019        PMID: 30900247     DOI: 10.1002/lary.27933

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  6 in total

1.  Transoral robotic thyroidectomy versus transoral endoscopic thyroidectomy: a propensity-score-matched analysis of surgical outcomes.

Authors:  Yu-Hsien Chen; Hoon-Yub Kim; Angkoon Anuwong; Ting-Shuo Huang; Quan-Yang Duh
Journal:  Surg Endosc       Date:  2020-10-27       Impact factor: 4.584

Review 2.  Complications of Trans-oral Endoscopic Thyroidectomy Vestibular Approach: A Systematic Review.

Authors:  Ellada Akritidou; Gerasimos Douridas; Eleftherios Spartalis; Gerasimos Tsourouflis; Dimitrios Dimitroulis; Nikolaos I Nikiteas
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

3.  Robotic-assisted parathyroidectomy via transaxillary approach: feasibility and learning curves.

Authors:  Emad Kandil; Deena Hadedeya; Mahmoud Shalaby; Eman Toraih; David Aparício; Meghan Garstka; Ruhul Munshi; Ahmed Elnahla; Jonathon O Russell; Patrick Aidan
Journal:  Gland Surg       Date:  2021-03

4.  The variable direct cost and cost drivers of transoral endoscopic thyroidectomy vestibular approach.

Authors:  Christopher R Razavi; Ved A Tanavde; Alexander S Kim; Mohammad Shaear; Ralph P Tufano; Jonathon O Russell
Journal:  Gland Surg       Date:  2021-02

Review 5.  Safety and Efficacy of Transoral Robotic Thyroidectomy for Thyroid Tumor: A Systematic Review and Meta-Analysis.

Authors:  Yun Jin Kang; Jin-Hee Cho; Gulnaz Stybayeva; Se Hwan Hwang
Journal:  Cancers (Basel)       Date:  2022-08-31       Impact factor: 6.575

6.  Cervical scar satisfaction post conventional thyroidectomy.

Authors:  Cherian Felix; Jonathon O Russell; Solaiman Juman; Steve Medford
Journal:  Gland Surg       Date:  2019-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.